November 21, 2026

HC rule on drug adulterating

The High Court has asked the government to explain why necessary measures, including the formation of observation cells, have not been taken to stop adulteration of medicine.

Staff Correspondent

bdnews24.com

Published : 28 Jan 2014, 04:22 PM

Updated : 08 Aug 2022, 06:26 PM

The bench of Justices Mirza Hussain Haider and Muhammad Khurshid Alam Sarkar sought the explanation on Tuesday after a primary hearing on a writ.

The Health Secretary, Law Secretary, Director General of Directorate General of Drug Administration (DGDA) and Director General of Directorate General of Health Services have been asked to respond within two weeks.

The court has also asked why a directive should not be issued for taking steps to fix the price of medicines produced by different pharmaceutical companies.

Related Stories